This compound is a protected intermediate for modified nucleosides, featuring a silyl-protected ribose moiety and a trityl-type protecting group. It is used in the synthesis of nucleoside analogs for pharmaceutical research and manufacturing.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 875302-41-3
5'-O-(4,4'-dimethoxitrityl)-3'-O-(tert-butyldimethylsilyl)-1-methylpseudouridine
Pharmaceutical intermediate for modified nucleoside synthesis
5'-O-(4,4'-dimethoxitrityl)-1-N-methylpseudouridine
Pharmaceutical intermediate for RNA synthesis
5'-O-DMT-2'-O-TBDMS-Pseudouridine
Pharmaceutical intermediate for nucleoside synthesis
5'-DMT-3'-O-TBDMS-N1-Me-Pseudouridine-CE-Phosphoramidite
Phosphoramidite building block for RNA synthesis
[3-[4-(4-aminobenzoyl)oxyphenyl]-2-(octadec-9-enoylamino)propyl] phosphate;[3-(4-iodophenyl)-2-(octadec-9-enoylamino)propyl] phosphate;[3-[4-[(3-methoxyphenyl)methoxy]phenyl]-2-(octadec-9-enoylamino)propyl] phosphate;bis([2-(octadec-9-enoylamino)-3-[4-[(4-pentylphenyl)methoxy]phenyl]propyl] phosphate);[2-(octadec-9-enoylamino)-3-(4-phenylphenyl)propyl] phosphate;[2-(octadec-9-enoylamino)-3-(4-prop-2-enoxyphenyl)propyl] phosphate
raw material for therapeutic antibody
(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyloxazolidin-2-one
Pharmaceutical intermediate for fine chemicals
(4-Fluoro-5-isopropyl-2-methoxyphenyl)boronic acid
Pharmaceutical intermediate
5'-DMT-3'-O-TBDMS-PseudoUridine
pharmaceutical intermediate for modified nucleosides
5-[(2S,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxyoxolan-2-yl]-1-methylpyrimidine-2,4-dione
LAUAFECHUGXCAW-NXVJRICRSA-N
CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H]([C@H](O[C@H]1C2=CN(C(=O)NC2=O)C)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O
—